The US healthcare environment has never seen more change than it has over the last year--posing new opportunities and advantages for healthtech companies entering and expanding their US presence. We'll talk about what's changed, lay out proven strategies for maximizing pilots and partnerships, and a few of the less obvious tactics to accelerate concrete commercial traction.
Leave with actionable concepts, an updated grasp of the US landscape, and warm connections to help your company grow.
Who should attend?
This session will specifically address the opportunities and challenges for both practitioner-driven and consumer medical devices, digital health, and diagnostics. For pharma, please contact us directly for insights.
◈ Entrepreneurs and commercial leaders with a ready-to-scale healthtech product who need to accelerate time-to-market while managing cost-of-entry
◈ Life science innovators exploring potential US partnerships--many accelerators, corporate ventures, and distributors we mention work across biotech and cleantech
◈ Scaleups running lean and evaluating nimble ways to climb the value chain in our fragmented, complex, and opaque healthcare ecosystem
➩10:00 AM - 10:30 AM: Keynote with straightforward answers and insights
➩10:30 AM - 11:00 AM: Roundtable conversation with corporate and startup perspectives
Want to submit a question?
✉ Drop the host an email at firstname.lastname@example.org --or join the live chat for Q&A.
Elizabeth Jennings leads US-based Venture Atlas Labs for healthcare commercialization and serves on the Board of Directors for SWAN Impact Network and the Texas Global Health Security Innovation Consortium. She is a frequent global speaker, practical advisor, and renowned palliative gardener.